• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022July

Month: July 2022

Stock News

Lido Finance: Reliant On Ethereum, But A Strong Governance Story (LDO-USD)

July 29, 2022 admin 0

putilich/iStock via Getty Images Lido Finance (LDO-USD) is a DeFi protocol that currently offers liquid staking on five well-known blockchains. For those not deep in the DeFi realm, liquid staking is the act of minting […]

Stock News

Fluence Energy: An Energy Storage Leader On Sale (NASDAQ:FLNC)

July 29, 2022 admin 0

Petmal Investment Thesis Fluence Energy, Inc. (NASDAQ:FLNC) operates in a market that will experience significant growth in the coming years: energy storage. With Siemens (OTCPK:SIEGY, OTCPK:SMAWF) and The AES Corporation (AES) present as major shareholders, […]

No Picture
Stock News

Financial Institutions, Inc. (FISI) CEO Marty Birmingham on Q2 2022 Results Earnings Call Transcript

July 29, 2022 admin 0

Financial Institutions, Inc. (NASDAQ:FISI) Q2 2022 Earnings Conference Call July 29, 2022 8:30 AM ET Company Participants Shelly Doran – Director of IR Marty Birmingham – President and CEO Jack Plants – CFO Justin Bigham […]

Posts navigation

« 1 … 155 156 157 … 2,356 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • US Dollar to Rise on Fed Minutes, G20 Summit Amid Ukraine War?
    July 6, 2022 0
  • Amazon launches home insurance portal in UK By Reuters
    October 19, 2022 0
  • Inhibikase Therapeutics, Inc. (IKT) CEO Milton Werner on Q2 2022 Results – Earnings Call Transcript
    August 15, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.